Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and Pediatric hematology/oncology/BMT patients:
All other patients: Duration of illness |
Initiate isolation when test is ordered to rule out viral pathogens. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Duration of illness |
Additional resources are available on the parechovirus web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Immunosuppressed patient |
For duration of hospitalization when chronic disease occurs |
Duration of precautions for immunosuppressed patients with persistently positive PCR not defined, but transmission has occurred. |
|
Patient with transient aplastic or red-cell crisis |
Seven days from symptom onset if known. Use date of identification if symptom onset date unclear. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 5 days of effective antibiotic therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
bubonic | |||
pneumonic |
Until 48 hrs after initiation of effective therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Staphylococcus aureus (nafcillin/methicillin sensitive OR resistant) | |||
Streptococcus pyogenes (group A strep) |
Until 24 hours after initiation of effective therapy |
||
Varicella-Zoster (See Varicella-Zoster) |
|
||
Viral, All patients |
See Respiratory Infectious Disease, acute, or specific viral agent |
||
Pneumonia, adenovirus |
|
Refer to Adenovirus-Respiratory Infection |
|
Bacterial, not listed elsewhere | |||
Burkholderia cepacia in cystic fibrosis patients, including respiratory tract colonization | |||
Burkholderia cepacia in patients without cystic fibrosis | |||
Chlamydia | |||
Fungal | |||
H. influenzae, Infants and children (any age) |
Until 24 hours after initiation of effective theraphy |
||
H. influenzae, All other patients |
Until 24 hours after initiation of effective theraphy |
||
Legionella | |||
Meningococcal (N.meningitidis) |
Until 24 hours after initiation of effective therapy |
||
Multidrug-resistant bacterial (see Multidrug-Resistant Organisms) |
|
||
Mycoplasma (primary atypical pneumonia) |
Duration of illness |